erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Liver Cirrhosis, Biliary D008105 12 associated lipids
Liver Diseases D008107 31 associated lipids
Long QT Syndrome D008133 10 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Diseases, Obstructive D008173 10 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lupus Erythematosus, Cutaneous D008178 2 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lyme Disease D008193 5 associated lipids
Lymphadenitis D008199 8 associated lipids
Lymphangitis D008205 4 associated lipids
Lymphogranuloma Venereum D008219 4 associated lipids
Mycetoma D008271 4 associated lipids
Marfan Syndrome D008382 2 associated lipids
Mastoiditis D008417 2 associated lipids
Maxillofacial Injuries D008446 1 associated lipids
Megacolon D008531 1 associated lipids
Meningitis, Haemophilus D008583 3 associated lipids
Meningitis, Listeria D008584 1 associated lipids
Microphthalmos D008850 1 associated lipids
Stomatognathic Diseases D009057 1 associated lipids
Multiple Myeloma D009101 13 associated lipids
Myasthenia Gravis D009157 5 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Mycoplasma Infections D009175 13 associated lipids
Mycoplasmatales Infections D009180 6 associated lipids
Myiasis D009198 1 associated lipids
Nasal Polyps D009298 26 associated lipids
Nasopharyngeal Diseases D009302 2 associated lipids
Nasopharyngitis D009304 2 associated lipids
Nausea D009325 7 associated lipids
Nephritis, Interstitial D009395 10 associated lipids
Nervous System Diseases D009422 37 associated lipids
Hereditary Sensory and Autonomic Neuropathies D009477 1 associated lipids
Neutropenia D009503 15 associated lipids
Nocardia Infections D009617 6 associated lipids
Obesity D009765 29 associated lipids
Endophthalmitis D009877 12 associated lipids
Ophthalmia Neonatorum D009878 1 associated lipids
Psittacosis D009956 4 associated lipids
Orthomyxoviridae Infections D009976 3 associated lipids
Osteitis D010000 10 associated lipids
Osteolysis D010014 8 associated lipids
Osteomyelitis D010019 10 associated lipids
Otitis D010031 5 associated lipids
Otitis Externa D010032 8 associated lipids
Otitis Media D010033 12 associated lipids
Otitis Media with Effusion D010034 9 associated lipids
Otitis Media, Suppurative D010035 4 associated lipids
Otorhinolaryngologic Diseases D010038 3 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Stickney RH et al. Chlamydia trachomatis: a cause of an infantile pneumonia syndrome. 1978 AJR Am J Roentgenol pmid:101061
Simakova MG et al. [Clinical aspects, diagnosis and treatment of intrauterine infections]. 1995 Akush Ginekol (Mosk) pmid:7485765
Mezinova NN et al. [Effect of anti-chlamydial drugs on the effectiveness of the treatment of habitual abortion]. 1991 Akush Ginekol (Mosk) pmid:1951968
Mezinova NN and Chuchupalov PD [Endometrial Chlamydia infection in women with habitual abortion]. 1992 Akush Ginekol (Mosk) pmid:1476220
Kotua EN and Moroz AF [Erythromycin-ascorbinate therapy of pregnant rats with staphylococcal infections caused by staphylococcal strains both sensitive and resistant to erythromycin]. 1971 Akush Ginekol (Mosk) pmid:5138198
Kotua EN and Moroz AF [Passage of erythromycin and ristomycin into blood, placenta, fetus and amniotic fluid during various stages of pregnancy in generalized staphylococcal infection in albino rats]. 1971 Akush Ginekol (Mosk) pmid:4328638
Thornton JB and Harris JH The prevention of bacterial endocarditis. A new approach to a changing disease. 1986 Ala J Med Sci pmid:3953983
BOURICHON J [Importance of the suppository form in the administration of propionyl-erythromycin to children]. 1962 Alger Medicale pmid:13871918
LEBON J et al. [Staphylococcal diarrhea after terramycin administration; cure by erythromycin]. 1955 Alger Medicale pmid:14398597
Ramirez B and Richter JE Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease. 1993 Aliment. Pharmacol. Ther. pmid:8094981
Catnach SM et al. Dose-dependent stimulation of gallbladder contraction by intravenous erythromycin in man. 1993 Aliment. Pharmacol. Ther. pmid:8439638
Verhagen MA et al. Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers. 1997 Aliment. Pharmacol. Ther. pmid:9663833
Talley NJ et al. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. 2000 Aliment. Pharmacol. Ther. pmid:11121915
Netzer P et al. Effects of ABT-229, a motilin agonist, on acid reflux, oesophageal motility and gastric emptying in patients with gastro-oesophageal reflux disease. 2002 Aliment. Pharmacol. Ther. pmid:12182748
Athanasakis E et al. Octreotide enhances the accelerating effect of erythromycin on gastric emptying in healthy subjects. 2002 Aliment. Pharmacol. Ther. pmid:12182757
van Erpecum KJ et al. Review article: agents affecting gall-bladder motility--role in treatment and prevention of gallstones. 2000 Aliment. Pharmacol. Ther. pmid:10903008
Chiba T et al. Motilides accelerate regional gastrointestinal transit in the dog. 2000 Aliment. Pharmacol. Ther. pmid:10886053
Jameson JS et al. Oral or intravenous erythromycin has no effect on human distal colonic motility. 1992 Aliment. Pharmacol. Ther. pmid:1420750
Laine L et al. Prospective evaluation of the macrolide antibiotic dirithromycin for the treatment of Helicobacter pylori. 1996 Aliment. Pharmacol. Ther. pmid:8791949
Wehrmann T et al. Effect of erythromycin on human biliary motility. 1996 Aliment. Pharmacol. Ther. pmid:8791972